Literature DB >> 21288293

Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats.

Lenore M Bacek1, Douglass K Macintire.   

Abstract

OBJECTIVE: To describe the use of oral mycophenolate mofetil (MMF) as an adjunctive therapy in 2 cats with primary immune-mediated hemolytic anemia. CASE SERIES
SUMMARY: Two cats suffering from presumptive primary immune mediated hemolytic were treated with MMF as part of their treatment regimens. Both cats had improved complete blood counts following therapy. NEW OR UNIQUE INFORMATION PROVIDED: This is the first reported use of oral MMF as adjunctive treatment for cats with immune-mediated hemolytic anemia. Outcome was favorable in both cats and no adverse effects were noted from the MMF. © Veterinary Emergency and Critical Care Society 2011.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21288293     DOI： 10.1111/j.1476-4431.2010.00606.x

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN： 1476-4431


  8 in total

1.  Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes.

Authors:  J E Slovak; K Mealey; M H Court
Journal:  J Vet Pharmacol Ther       Date:  2016-06-15       Impact factor: 1.786

2.  Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds.

Authors:  M Grobman; D M Boothe; H Rindt; B G Williamson; M L Katz; J R Coates; C R Reinero
Journal:  J Vet Pharmacol Ther       Date:  2017-06-25       Impact factor: 1.786

3.  Successful treatment and long-term follow up of idiopathic immune-mediated polyarthritis with mycophenolate mofetil in a cat.

Authors:  Yu Tamura; Tetsuro Nagamoto; Kazuhito Segawa; Sakurako Neo; Hirotaka Igarashi; Masaharu Hisasue
Journal:  JFMS Open Rep       Date:  2020-11-02

4.  Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats.

Authors:  Jennifer E Slovak; Julianne K Hwang; Sol M Rivera; Nicolas F Villarino
Journal:  J Vet Intern Med       Date:  2019-08-19       Impact factor: 3.333

5.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

6.  Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats.

Authors:  J E Slovak; S M Rivera; J K Hwang; M H Court; N F Villarino
Journal:  J Vet Intern Med       Date:  2017-09-11       Impact factor: 3.333

7.  Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).

Authors:  Andrew D Woolcock; Andrea Wang; Allison Haley; Marc Kent; Kate E Creevy; Simon R Platt
Journal:  Vet Med Sci       Date:  2016-02-10

8.  Suspected hepatopathy and pancreatitis associated with mycophenolate mofetil use in a cat with immune-mediated haemolytic anaemia.

Authors:  Matthew A Kopke; Pru E J Galloway
Journal:  JFMS Open Rep       Date:  2020-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.